Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by rapidly progressive degeneration of motor neurons in the brain and spinal cord. Although most forms of ALS are sporadic (sALS), ∼10% of cases are inherited in families (fALS). More than 50 ALS genes have been identified, with 16 of them unequivocally implicated in the pathogenesis (1) . These genes function in a wide spectrum of cellular processes, which has posed a considerable challenge in understanding common genetic causes of ALS. Another major question in ALS, and neurodegeneration in general, is related to the selectivity of neuronal cell death. Why is toxicity of mutant genes detrimental to certain types of neuronal cells, while leaving others unaffected? In the case of ALS, motor neurons are selectively degenerated. In PNAS, Ciryam et al. (2) investigate the expression level relative to protein solubility for ALS-associated proteins. Their results indicate that these proteins, compared with the whole proteome, are "supersaturated." Furthermore, coaggregating proteins in inclusion bodies appear to be significantly more supersaturated in motor neurons than in other tissue types. These findings provide a plausible explanation for two aspects of ALS pathology: genetic heterogeneity and motor neuron-specific toxicity.
Genetic Heterogeneity of ALS
One of the biggest breakthroughs in ALS research has been the identification of mutations in ALS-causing genes. The first gene linked to ALS was SOD1 in 1993 (3). SOD1 encodes a cytosolic Cu/Zn superoxide dismutase that catalyzes the dismutation of toxic superoxide anion to oxygen and hydrogen peroxide. Mutations in SOD1 account for ∼20% of fALS cases. The field was highly energized by this important discovery, expecting that it would lead to mechanistic understanding of the disease and ultimately development of effective therapeutics for this devastating disease. SOD1 and its associated mutations have since been modeled in a wide range of systems, including yeast, neuronal cell, induced pluripotent stem cells, and many transgenic animals, such as mouse, rat, dog, fly, and worm (4). Indeed, the studies of SOD1-mediated pathology have contributed greatly to our current understanding of the disease. The proposed pathological mechanisms include oxidative damage, mitochondrial dysfunction, endoplasmic reticulum stress, dysfunctional axonal transport, and proteasome inhibition (5) . More recently, with the development of new sequencing technology, many other fALS genes have been discovered that collectively account for majority of the remaining fALS cases. These include the genes coding for the TAR-DNA-binding protein (TDP-43), fused in liposarcoma protein (FUS), guanine nucleotide exchange factor C9ORF72, autophagy adaptor protein optineurin (OPTN) and ubiquilin 2 (UBQLN2), and RNA binding protein matrin 3 (MATR3) (1). Of these genes, TDP-43, FUS, and C9ORF72 are of special interest, not only because they account for the most cases of fALS, but also, all are connected with different aspects of RNA metabolism, raising a new possibility that RNA quality control may be central to ALS pathology. Despite the success so far, a sobering reality is that no consensus mechanism has been proposed for the cellular toxicity of ALSassociated genes and selective degeneration of motor neurons, indicating the complex nature and remarkable genetic heterogeneity of ALS. 
Supersaturated ALS Proteins
A hallmark of ALS pathology is the presence of protein inclusions in disease-affected neurons. These inclusions are often composed of the proteins SOD1, TDP-43, and FUS, along with a number of other coaggregating proteins. In their paper, Ciryam et al. (2) curated a comprehensive list of native interactors and coaggregators in the inclusion bodies of SOD1, TDP-43, and FUS. Based on the experimental data providing mRNA and protein concentration and predicted aggregation propensities of each protein (6), Ciryam et al. (2) found that SOD1, TDP-43, and FUS, as well as their native interactors and coaggregators, are supersaturated. Given the fact that SOD1, TDP-43, and FUS themselves are prone to aggregation (7), it would seem highly plausible that the coaggregating proteins are a subset of the native interactors that get pulled into the inclusions because of their interaction with the primary aggregating proteins. However, Ciryam et al. (2) identified that coaggregators within the inclusions, for the most part, are distinct from the native interactors of SOD1, TDP-43, or FUS, challenging the idea of a simple pull-down. Using data generated from this paper, as well as existing Kyoto Encyclopedia of Genes and Genomes ALS pathways, Ciryam et al. generated an ALS network encompassing the ALS-associated genes. Interestingly, almost all of the cellular pathways in this network contain at least one supersaturated protein (2) . This finding suggests that, rather than dysfunction in a single pathway, global disruption of protein homeostasis, governed by the physicochemical properties of the proteins involved, is underlying ALS pathology. This observation is in line with the genetic heterogeneity of ALS, with diseaseassociated mutations occurring in a functionally diverse set of genes.
Motor Neuron-Specific Pathology of ALS
Motor neuron cells are selectively damaged in ALS. Genes associated with ALS, however, are ubiquitously expressed, resulting in the question of what other factors make these cells particularly vulnerable to neurodegeneration. Could the motor neuron specific proteome be responsible? For example, if there is an abundance of aggregation-prone proteins that are more supersaturated in motor neurons, these proteins may be at higher risk for forming pathological inclusions during insult from environmental toxins, gene mutations, cellular stress, or aging (Fig. 1) , tipping the balance of the protein homeostasis. To test this possibility, Ciryam et al. (2) compared the level of supersaturation of coaggregators or native interactors of SOD1, TDP-43, and FUS from three different samples: whole tissue averaged from a number of different cell types, microdissected motor neurons, and motor neurons from ALS patient tissue. A significantly higher level of supersaturation was observed for coaggregators than native interactors in motor neurons, which was not obvious in the whole-tissue sample (2), suggesting the presence of motor neuron-specific inclusions and selective vulnerability.
Remaining Questions and Future Directions
Ciryam et al. (2) focused on ALS-associated proteins SOD1, TDP-43, and FUS, and found that they are supersaturated, and so are their native interactors and coaggregators. Given that TDP-43 and FUS have been shown to be intrinsically aggregation-prone (8) , and SOD1 is one of the most abundant cellular proteins (9) (10) . It will be interesting to check whether a difference in protein supersaturation accounts for this differential vulnerability. In addition, it has recently been shown by the same group that biochemical pathways associated with Alzheimer's, Parkinson's, and Huntington's diseases are all enriched in supersaturated proteins (11) (12) (13) . As such, what is the uniqueness and difference among them? From a therapeutic perspective, can we "cure" ALS or other neurodegenerative disorder by regulating some of these supersaturated proteins? If so, is only one protein responsible for initiating the collapse of protein homeostasis (Fig. 1) within motor neurons and could that protein serve as a main target for therapeutic intervention? Alternatively, can we develop ways to strengthen protein homeostasis in the face of supersaturation?
